DCM Shriram Fine Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
DSFCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.5 pts less than Nifty Microcap 250 and 8.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DCM Shriram Fine Chemicals submitted its first quarterly results as a listed entity (shares listed on BSE/NSE on Feb 17, 2026), following the December 2025 effectiveness of a Composite Scheme of Arrangement that merged chemical operations from DCM Shriram Industries into the company. Standalone Q3 FY26 revenue from operations was Rs. 9,601 lakhs versus Rs. 9,269 lakhs in Q3 FY25, a modest 3.6% growth, but the company swung to a net loss of Rs. 162 lakhs from a net profit of Rs. 220 lakhs a year ago. For 9M FY26, revenue was Rs. 29,016 lakhs (vs Rs. 28,007 lakhs) with a small net loss of Rs. 23 lakhs versus a profit of Rs. 1,419 lakhs in 9M FY25. The company also recognised an exceptional Rs. 533 lakhs impairment on a Dahej leasehold land in Q2, of which Rs. 223 lakhs was reversed in Q3 upon sale. Auditor Kirtane & Pandit LLP issued an unmodified (clean) limited review report on both standalone and consolidated results.
Despite slightly higher revenue, sharp margin compression pushed the company into a quarterly loss and a marginal loss for the nine-month period, a clear reversal from last year's profitability. Shareholders should watch upcoming quarters to see if the new post-demerger standalone entity can restore margins, as this weak debut print may weigh on the recently listed stock in the near term.